BioCentury
ARTICLE | Clinical News

Combigan regulatory update

November 5, 2007 8:00 AM UTC

FDA approved AGN'S Combigan 0.2% brimonidine/0.5% timolol solution as an adjunctive or replacement therapy to reduce inadequately controlled intraocular pressure (IOP) in patients with glaucoma or ocu...